0001209191-18-045747.txt : 20180807
0001209191-18-045747.hdr.sgml : 20180807
20180807175527
ACCESSION NUMBER: 0001209191-18-045747
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180806
FILED AS OF DATE: 20180807
DATE AS OF CHANGE: 20180807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hanley Samantha
CENTRAL INDEX KEY: 0001632229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10638
FILM NUMBER: 18999333
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: EAST RUTHERFORD
STATE: NJ
ZIP: 07073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAMBREX CORP
CENTRAL INDEX KEY: 0000820081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222476135
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MEADOWLANDS PLZ
CITY: E RUTHERFORD
STATE: NJ
ZIP: 07073
BUSINESS PHONE: 2018043000
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: E. RUTHERFORD
STATE: NJ
ZIP: 07073
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-06
0
0000820081
CAMBREX CORP
CBM
0001632229
Hanley Samantha
ONE MEADOWLANDS PLAZA
EAST RUTHERFORD
NJ
07073
0
1
0
0
VP, General Counsel
Common Stock
2018-08-06
4
M
0
2500
16.905
A
2500
D
Common Stock
2018-08-06
4
M
0
2500
17.81
A
5000
D
Common Stock
2018-08-06
4
M
0
3750
22.495
A
8750
D
Common Stock
2018-08-06
4
M
0
12500
41.355
A
21250
D
Common Stock
2018-08-06
4
M
0
6250
40.65
A
27500
D
Common Stock
2018-08-06
4
S
0
19900
62.36
D
7600
D
Common Stock
2018-08-06
4
S
0
7600
63.38
D
0
D
Stock Option (right to buy)
16.905
2018-08-06
4
M
0
2500
0.00
A
2020-10-28
Common Stock
2500
0
D
Stock Option (right to buy)
17.81
2018-08-06
4
M
0
2500
0.00
A
2021-10-22
Common Stock
2500
2500
D
Stock Option (right to buy)
22.495
2018-08-06
4
M
0
3750
0.00
A
2022-01-28
Common Stock
3750
3750
D
Stock Option (right to buy)
41.355
2018-08-06
4
M
0
12500
0.00
A
2022-10-21
Common Stock
12500
12500
D
Stock Option (right to buy)
40.65
2018-08-06
4
M
0
6250
0.00
A
2023-10-26
Common Stock
6250
18750
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.95 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.05 to $63.68 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
The option representing a right to purchase 10,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 10,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 15,000 shares became exercisable in four equal installments beginning January 28, 2016, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 21, 2016, which was the first anniversary of the date on which the option was granted
The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted
/s/ Samantha Hanley
2018-08-07